Emmanuelle Filippi

Intravenous enoxaparin or unfractionated heparin in primary percutaneous coronary intervention for ST-elevation myocardial infarction: the international randomised open-label ATOLL trial

Gilles Montalescot, Uwe Zeymer, Johanne Silvain et al. · The Lancet · 2011 · 313 citations

Thrombosis, Percutaneous Coronary Intervention, Cardiovascular Disease +12

Ticagrelor versus clopidogrel in elective percutaneous coronary intervention (ALPHEUS): a randomised, open-label, phase 3b trial

Johanne Silvain, Benoît Lattuca, Farzin Beygui et al. · The Lancet · 2020 · 122 citations · Full text

Percutaneous Coronary Intervention, Thrombosis, Cardiovascular Disease +10

Gender differences in presentation, management and inhospital outcome in patients with ST-segment elevation myocardial infarction: Data from 5000 patients included in the ORBI prospective French regional registry

Guillaume Leurent, Ronan Garlantézec, Vincent Auffret et al. · Archives of cardiovascular diseases · 2014 · 99 citations · Full text

Inhospital Outcome, Cardiovascular Epidemiology, Cardiovascular Disease +12

High-degree atrioventricular block complicating ST segment elevation myocardial infarction in the contemporary era

Vincent Auffret, Aurélie Loirat, Guillaume Leurent et al. · Heart · 2015 · 73 citations

A Direct Comparison of Intravenous Enoxaparin With Unfractionated Heparin in Primary Percutaneous Coronary Intervention (from the ATOLL Trial)

Jean‐Philippe Collet, Kurt Huber, Marc Cohen et al. · The American Journal of Cardiology · 2013 · 56 citations

Thrombosis, Percutaneous Coronary Intervention, Atoll Trial +14